好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Predictors of Functional Recovery after Mechanical Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation
Cerebrovascular Disease and Interventional Neurology
P8 - Poster Session 8 (11:45 AM-12:45 PM)
6-012
To identify predictors of functional improvement in patients with acute ischemic stroke of the posterior circulation who undergo mechanical thrombectomy.

Up to date, clinical trials have yielded conflicting results regarding the efficacy and safety of mechanical thrombectomy (MT) for acute ischemic strokes (AIS) of the posterior circulation (PC). It is urgent to identify factor associated with better outcomes and to improve patients’ selection.

We collected data from patients with AIS of the PC who underwent MT in a comprehensive stroke center, from 2015 to 2022. We registered demographic, clinical, and imaging information. Main outcome of interest was functional recovery at ninety-days, measured with the modified Rankin Scale (mRS); we defined good functional recovery as mRS 0-2, and fair as mRS 0-3. We used Bayesian Model Averaging (BMA) to identify variables correlated with good and fair functional outcome, with a posterior probability cut-off of 60%. Analyses were conducted using R software.

Eighty-nine patients met our inclusion criteria. Median age was 65 (IQR 55-76) and 37.9% (n= 36) were female. Mean basal mRS was 0.4 (SD 0.9), median pc-ASPECTS was 9 (IQR 8-10), 38.2% (n=34) received IV-tPA, and median NIHSS at admission was 17 (IQR 10-28). Median SO-to-puncture time was 534.5 min (IQR 339-944). In 77.5% (n=60) reperfusion (mTICI 2b-3) was achieved, 29.8% (n=25/84) had good mRS at 90-days, and 47.6% (n=40/84) fair mRS. In BMA analysis for fair mRS, NIHSS at admission (prob-not-0=66.6, OR-post-mean=0.96) and hemorrhagic conversion (prob-not-0=61.1, OR-post-mean=0.4) were selected as predictors in the 5 best models. For good mRS, only coronary artery disease (prob-not-0=62.9, OR-post-mean=0.25) was selected.

Lower NIHSS at admission was positive correlated with better functional recovery at 90-days, while hemorrhagic conversion and CAD showed a negative correlation. Our results are limited for the small sample size and retrospective design, however, using BMA allows for strongly reliable results.

Authors/Disclosures
Milagros Galecio-Castillo, MD
PRESENTER
Dr. Galecio-Castillo has nothing to disclose.
Juan J. Mendez Gallardo, MD (Instituto Nacional De Neurologia Y Neurocirugia) Dr. Mendez Gallardo has nothing to disclose.
Aaron E. Rodriguez-Calienes (University of Iowa Hospitals and Clinics) Dr. Rodriguez-Calienes has nothing to disclose.
No disclosure on file
Mudassir Farooqui, MD Dr. Farooqui has nothing to disclose.
Santiago Ortega Gutierrez, MD (University of Iowa) Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH. The institution of Dr. Ortega Gutierrez has received research support from PCORI.
Juan A. Vivanco-Suarez, MD Mr. Vivanco-Suarez has nothing to disclose.